Anti-Human CD38 Recombinant Antibody(Daratumumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD38 Recombinant Antibody(Daratumumab)

Anti-Human CD38 Recombinant Antibody(Daratumumab)

产品编号

YR1199

别名

科研级Daratumumab, Anti-CD38 Recombinant Antibody, Research Grade Daratumumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级Daratumumab, Anti-CD38 Recombinant Antibody, Research Grade Daratumumab
Catalog Number	YR1199
Molecular Name	Daratumumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab.
CAS Number	945721-28-8
Application	WB, IP, IF, FuncS, FCM, Neut, ELISA
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	148 kDa
Target	CD38[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0

可以介绍下你们的产品么

你们是怎么收费的呢

现在有优惠活动吗

请您留言

感谢您的关注，当前客服人员不在线，请填写一下您的信息，我们会尽快和您联系。

提交